Surgery Partners, Inc. (SGRY) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 578.50M USD | Liabilities, Current |
| Cash and equivalents | 216.70M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 616.60M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 98.80M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $578.50M | $216.70M | (m) | $616.60M | $98.80M | (m) |
| 2026-03-31 | (m) | $581.70M | $182.30M | (m) | $603.40M | $100.50M | (m) |
| 2025-12-31 | (m) | $615.50M | $239.90M | (m) | $602.20M | $96.60M | (m) |
| 2025-09-30 | (m) | $586.00M | $203.40M | (m) | $579.30M | $92.30M | (m) |
| 2025-06-30 | (m) | $573.30M | $250.10M | (m) | $563.10M | $87.30M | (m) |
| 2025-03-31 | (m) | $569.40M | $229.30M | (m) | $570.60M | $88.10M | (m) |
| 2024-12-31 | (m) | $624.40M | $269.50M | (m) | $579.10M | $88.40M | (m) |
| 2024-09-30 | (m) | $575.20M | $221.80M | (m) | $542.90M | $82.00M | (m) |
| 2024-06-30 | (m) | $551.80M | $213.50M | (m) | $523.40M | $80.90M | (m) |
| 2024-03-31 | (m) | $523.40M | $185.20M | (m) | $494.30M | $77.00M | (m) |
| 2023-12-31 | (m) | $523.00M | $195.90M | (m) | $496.40M | $75.20M | (m) |
| 2023-09-30 | (m) | $501.40M | $236.00M | (m) | $462.80M | $69.40M | (m) |
| 2023-06-30 | (m) | $458.60M | $177.40M | (m) | $449.90M | $70.30M | (m) |
| 2023-03-31 | (m) | $475.10M | $245.50M | (m) | $452.90M | $71.80M | (m) |
| 2022-12-31 | (m) | $493.40M | $282.90M | (m) | $456.30M | $71.40M | (m) |
| 2022-09-30 | (m) | $624.30M | $154.80M | (m) | $422.30M | $68.60M | (m) |
| 2022-06-30 | (m) | $521.70M | $227.40M | (m) | $412.00M | $64.00M | (m) |
| 2022-03-31 | (m) | $542.30M | $378.90M | (m) | $412.40M | $62.90M | (m) |
| 2021-12-31 | (m) | $536.80M | $389.90M | (m) | $430.20M | $61.10M | (m) |
| 2021-09-30 | (m) | $540.50M | $330.40M | (m) | $393.40M | $59.30M | (m) |
| 2021-06-30 | (m) | $531.90M | $464.80M | (m) | $374.90M | $57.30M | (m) |
| 2021-03-31 | (m) | $574.80M | $541.90M | (m) | $367.00M | $56.10M | (m) |
| 2020-12-31 | (m) | $556.80M | $317.90M | (m) | $382.20M | $56.40M | (m) |
| 2020-09-30 | (m) | $590.90M | $450.00M | (m) | $337.00M | $50.90M | (m) |
| 2020-06-30 | (m) | $571.20M | $326.30M | (m) | $310.90M | $49.00M | (m) |
| 2020-03-31 | (m) | $411.70M | $194.60M | (m) | $311.70M | $49.00M | (m) |
| 2019-12-31 | (m) | $398.10M | $92.70M | (m) | $326.90M | $46.30M | (m) |
| 2019-09-30 | (m) | $381.50M | $111.30M | (m) | $303.10M | $44.40M | (m) |
| 2019-06-30 | (m) | $368.80M | $117.40M | (m) | $301.90M | $44.00M | (m) |
| 2019-03-31 | (m) | $359.60M | $142.50M | (m) | $294.90M | $43.80M | (m) |
| 2018-12-31 | (m) | $349.30M | $184.31M | (m) | $307.64M | $43.36M | (m) |
| 2018-09-30 | (m) | $295.59M | $79.12M | (m) | $286.26M | $44.36M | (m) |
| 2018-06-30 | (m) | $296.77M | $96.07M | (m) | $276.85M | $45.70M | (m) |
| 2018-03-31 | (m) | $285.75M | $112.82M | (m) | $275.34M | $48.10M | (m) |
| 2017-12-31 | (m) | $303.00M | $174.91M | (m) | $288.02M | $44.95M | (m) |
| 2017-09-30 | (m) | $275.01M | $199.70M | (m) | $271.14M | $44.52M | (m) |
| 2017-08-31 | (m) | (m) | $214.21M | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | $186.00M | $57.03M | (m) | $215.29M | $29.68M | (m) |
| 2017-03-31 | (m) | $196.46M | $55.97M | (m) | $218.01M | $29.34M | (m) |
| 2016-12-31 | (m) | $186.72M | $69.70M | (m) | $220.59M | $28.78M | (m) |
| 2016-09-30 | (m) | $178.65M | $55.21M | (m) | $205.98M | $26.87M | (m) |
| 2016-06-30 | (m) | $182.44M | $51.60M | (m) | $202.74M | $25.93M | (m) |
| 2016-03-31 | (m) | $183.78M | $135.05M | (m) | $185.88M | $26.55M | (m) |
| 2015-12-31 | (m) | $181.31M | $57.93M | (m) | $177.76M | $25.59M | (m) |
| 2015-09-30 | (m) | $176.18M | $56.85M | (m) | $164.60M | $24.75M | (m) |
| 2015-06-30 | (m) | (m) | $47.91M | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | $56.44M | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $141.39M | $74.92M | (m) | $144.96M | $23.69M | (m) |
| 2014-09-30 | (m) | (m) | $4.39M | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | $13.03M | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | $5.23M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ardent Health, Inc. (ARDT) | United States | $1.478B | 17.91 |
| COMMUNITY HEALTH SYSTEMS INC (CYH) | United States | $0.405B | 1.87 |
| TENET HEALTHCARE CORP (THC) | United States | $20.097B | |
| HCA Healthcare, Inc. (HCA) | United States | $93.934B | 15.49 |